학술논문
Complete hematologic response after belinostat treatment and allogeneic stem cell transplantation for multiple relapsed/refractory angioimmunoblastic T‐cell lymphoma: A case report.
Document Type
Case Study
Author
Camus, Vincent; Etancelin, Pascaline; Drieux, Fanny; Veresezan, Elena‐Liana; Picquenot, Jean‐Michel; Penther, Dominique; Viennot, Mathieu; Ruminy, Philippe; Contentin, Nathalie; Lemasle, Emilie; Leprêtre, Stéphane; Dubois, Sydney; Penichoux, Juliette; Stamatoullas, Aspasia; Zduniak, Alexandra; Lanic, Hélène; Jardin, Fabrice
Source
Subject
*STEM cell transplantation
*T-cell lymphoma
*STEM cell treatment
*
*
Language
ISSN
2050-0904
Abstract
Key Clinical Message: This case report highlights the potential of belinostat for the treatment of relapsed/refractory peripheral T‐cell lymphomas, for which effective therapies are still scarce. Peripheral T‐cell lymphomas have an aggressive disease course associated with poor outcomes. We report a young patient with highly pretreated relapsed/refractory nodal follicular helper T‐cell lymphoma (angioimmunoblastic‐type [nTFHL‐AI]), who successfully received an allogeneic stem cell transplantation following belinostat therapy. The complete hematologic response achieved has lasted more than 2 years. [ABSTRACT FROM AUTHOR]